NEW YORK (GenomeWeb) – Becton Dickinson said today that the US Food and Drug Administration has given it 510(k) clearance for a molecular test that detects infectious diarrhea caused by harmful intestinal bacteria.

The test is an extension to the firm's BD MAX real-time PCR enteric bacterial panel. With the clearance, the majority of pathogens causing acute gastroenteritis leading to hospitalization can be detected rapidly and accurately on the fully automated BD MAX molecular platform, BD said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.